HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment with apremilast of severe psoriasis exacerbation during nivolumab therapy for metastatic melanoma.

AuthorsCaterina Foti, Marco Tucci, Luca Stingeni, Katharina Hansel, Lucia Lospalluti, Rosa Frisario, Roberta Giuffrida, Paolo Romita
JournalDermatologic therapy (Dermatol Ther) Vol. 34 Issue 1 Pg. e14653 (01 2021) ISSN: 1529-8019 [Electronic] United States
PMID33301205 (Publication Type: Letter)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Nivolumab
  • Thalidomide
  • apremilast
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Humans
  • Melanoma (drug therapy)
  • Nivolumab (adverse effects)
  • Psoriasis (diagnosis, drug therapy)
  • Severity of Illness Index
  • Thalidomide (adverse effects, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: